Cargando…

Gender Disparities in Anti-dementia Medication Use among Older Adults: Health Equity Considerations and Management of Alzheimer's Disease and Related Dementias

Objective: The prevalence of Alzheimer’s disease and related dementias (ADRD) in women is higher than men. However, the knowledge of gender disparity in ADRD treatment is limited. Therefore, this study aimed to determine the gender disparities in the receipt of anti-dementia medications among Medica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Z. Kevin, Xiong, Xiaomo, Wang, Xinyuan, Wu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424001/ https://www.ncbi.nlm.nih.gov/pubmed/34512340 http://dx.doi.org/10.3389/fphar.2021.706762

Ejemplares similares

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia
por: Hsieh, Stephanie, et al.
Publicado: (2021)

Impact of Alzheimer’s disease and related dementias on colorectal cancer screening utilization, knowledge, and associated health disparities
por: Lv, Gang, et al.
Publicado: (2022)

Racial and ethnic disparities in Alzheimer’s dementia
por: Lim, Unhee, et al.
Publicado: (2022)

Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review
por: Nicholls, Stuart G., et al.
Publicado: (2023)

Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare
por: Lu, Z. Kevin, et al.
Publicado: (2021)

Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer’s Disease
por: Gottesman, Reena T., et al.
Publicado: (2019)

Decomposition of Disparities in Alzheimer’s Disease and Related Dementia
por: Akushevich, Igor
Publicado: (2021)

A Prescribing Cascade of Proton Pump Inhibitors Following Anticholinergic Medications in Older Adults With Dementia
por: Trenaman, Shanna C., et al.
Publicado: (2022)

Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia
por: Ahuja, Rajiv, et al.
Publicado: (2021)

Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia
por: Ahuja, Rajiv, et al.
Publicado: (2021)

Trends in prevalence, health disparities, and early detection of dementia: A 10-year nationally representative serial cross-sectional and cohort study
por: Lu, Kevin, et al.
Publicado: (2023)

Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus
por: Yuan, Jing, et al.
Publicado: (2022)

Research progress in traditional Chinese medicine in the treatment of Alzheimer’s disease and related dementias
por: Tan, Wanying, et al.
Publicado: (2022)

Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis
por: Zhao, Mengnan, et al.
Publicado: (2023)

Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management
por: Xiong, Xiaomo, et al.
Publicado: (2021)

Achieving Healthcare Equity: Disparities in Diagnosis, Quality of Care, and Outcomes Among People With Dementia
por: Rivera-Hernandez, Maricruz, et al.
Publicado: (2020)

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
por: Ortner, Marion, et al.
Publicado: (2020)

OPTIMAL MEDICATION MANAGEMENT IN ALZHEIMER’S DISEASE AND DEMENTIA
por: Green, Ariel
Publicado: (2019)

Considering sex and gender in Alzheimer disease and other dementias
por: Podcasy, Jessica L., et al.
Publicado: (2016)

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer’s dementia using OMOP CDM
por: Byun, JungHyun, et al.
Publicado: (2022)

Are Anticholinergic Medications Associated With Increased Risk of Dementia and Behavioral and Psychological Symptoms of Dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan
por: Liu, Yia-Ping, et al.
Publicado: (2020)

Forkhead transcription factors: new considerations for alzheimer’s disease and dementia
por: Maiese, Kenneth
Publicado: (2016)

Partitioning Analysis of Disparities and Time Trends in Alzheimer’s Disease and Related Dementia
por: Akushevich, Igor
Publicado: (2020)

Real-world effects of anti-dementia treatment on mortality in patients with Alzheimer´s dementia
por: Nielsen, René Ernst, et al.
Publicado: (2022)

Alterations of Astrocytes in the Context of Schizophrenic Dementia
por: Tarasov, Vadim V., et al.
Publicado: (2020)

Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
por: Lu, Z. Kevin, et al.
Publicado: (2021)

Corrigendum: Big Data and Real-World Data Based Cost-Effectiveness Studies and Decision-Making Models: A Systematic Review and Analysis
por: Lu, Z. Kevin, et al.
Publicado: (2022)

Evidence of Chinese Herbal Medicine Use From an Economic Perspective: A Systematic Review of Pharmacoeconomics Studies Over Two Decades
por: Xiong, Xiaomo, et al.
Publicado: (2022)

Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis
por: Yunusa, Ismaeel, et al.
Publicado: (2020)

Beyond Sex: Gender, LGBTQ, and Alzheimer’s Disease and Related Dementias
por: Shaaban, C Elizabeth, et al.
Publicado: (2020)

Exploring the gender gap in end-of-life care: ethical considerations for dementia patients
por: Yakov, G, et al.
Publicado: (2023)

Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update
por: Khan, Sabiya Samim, et al.
Publicado: (2023)

Potentially Inappropriate Medication Among People With Dementia in China: A Nationwide Cross-Sectional Study
por: Zhao, Mengnan, et al.
Publicado: (2022)

Pathways Connecting Late-Life Depression and Dementia
por: Linnemann, Christoph, et al.
Publicado: (2020)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
por: Machado-Duque, Manuel Enrique, et al.
Publicado: (2021)

Racial and Ethnic Disparities in Quality Measures for People With Alzheimer’s Disease and Related Dementias
por: Rivera-Hernandez, Maricruz, et al.
Publicado: (2020)

Causes and Mechanisms Underlying Disparities and Time Trends in Alzheimer’s Disease and Related Dementias
por: Akushevich, Igor, et al.
Publicado: (2020)

Neurovascular Dysfunction in Diverse Communities With Health Disparities—Contributions to Dementia and Alzheimer’s Disease
por: Saiyasit, Napatsorn, et al.
Publicado: (2022)

Cost-Related Medication Nonadherence (CRN) on Healthcare Utilization and Patient-Reported Outcomes: Considerations in Managing Medicare Beneficiaries on Antidepressants
por: Alnijadi, Abdulrahman A., et al.
Publicado: (2021)

Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia
por: Ng, Kok Pin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5ooa7fp83la6mqlplhui5j7a8l